A

publication of the International Myeloma Foundation

14th Annual Summit of the IMF’s IMWG

Top experts in myeloma focus on MGUS, SMM, MRD, frontline therapy, relapse, as well as new and emerging immunotherapies

Key Myeloma Abstracts from 2023 ASCO & EHA

Exciting data presented on immunotherapies and the management of patients with relapsed myeloma, and much more! PAGE 8

ALSO IN THIS EDITION:

CAR T-cell therapy in the setting of earlier relapse

Clinical trial data presented at ASCO and EHA demonstrate the promise of CAR T­ cell therapies earlier in the course of myeloma PAGE 9

IMF Honors Two Outstanding Researchers

Dr. Mateos is recipient of the Robert A. Kyle Lifetime Achievement Award and Dr. Martin receives the Brian G.M. Durie Outstanding Achievement Award PAGE 10

Research Presented At Asco And Eha In 2023

Top

Dr. Brian G.M. Durie discusses the research presented at 2023 ASCO and EHA with panelists Mira Armour (leader of Mijelom CRO, Croatia) and Jack Aiello (28 ­year survivor and leader of the San Francisco support group). Watch this video IMF Chief Medical Officer DR. JOSEPH MIKHAEL Answers your myeloma questions LIVE on Facebook.

Dr. Joseph Mikhael goes LIVE to answer your myeloma questions in the return of his popular “Ask Me Anything” session. Join him on Facebook LIVE or watch the video replay. Watch now publications.myeloma.org

• Booklets that explain myeloma therapies and more

• Tip cards on topics important to myeloma patients

• Guide to Myeloma Acronyms and Abbreviations

• Guide to Myeloma Terms and Definitions

• Myeloma Today Spring 2023 edition